Cargando…
Identification of Early Diagnostic and Prognostic Biomarkers via WGCNA in Stomach Adenocarcinoma
Stomach adenocarcinoma (STAD) is a leading cause of cancer deaths, and the outcome of the patients remains dismal for the lack of effective biomarkers of early detection. Recent studies have elucidated the landscape of genomic alterations of gastric cancer and reveal some biomarkers of advanced-stag...
Autores principales: | Tan, Ruoyue, Zhang, Guanghui, Liu, Ruochen, Hou, Jianbing, Dong, Zhen, Deng, Chaowei, Wan, Sicheng, Lai, Xiaodong, Cui, Hongjuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249817/ https://www.ncbi.nlm.nih.gov/pubmed/34221961 http://dx.doi.org/10.3389/fonc.2021.636461 |
Ejemplares similares
-
WGCNA identification of TLR7 as a novel diagnostic biomarker, progression and prognostic indicator, and immunotherapeutic target for stomach adenocarcinoma
por: Yuan, Qihang, et al.
Publicado: (2021) -
Identification of therapeutic targets and prognostic biomarkers in cholangiocarcinoma via WGCNA
por: Xu, Lei, et al.
Publicado: (2022) -
Computed Tomography Features and Clinical Prognostic Characteristics of Hepatoid Adenocarcinoma of the Stomach
por: Huang, Wen-peng, et al.
Publicado: (2021) -
Construction of T cell exhaustion model for predicting survival and immunotherapy effect of bladder cancer based on WGCNA
por: Xue, Yuwen, et al.
Publicado: (2023) -
Screening Protein Prognostic Biomarkers for Stomach Adenocarcinoma Based on The Cancer Proteome Atlas
por: Zheng, Guo-Liang, et al.
Publicado: (2022)